Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
Drug News & Perspectives
|
April 19, 2007
Enrichment of a squamous carcinoma vaccine
InSug O-Sullivan, Amla Chopra, Edward P Cohen
International Journal of Molecular Sciences
|
June 19, 2024
N-Acetylgalactosamine-4-sulfatase (Arylsulfatase B) Regulates PD-L1 Expression in Melanoma by an HDAC3-Mediated Epigenetic Mechanism
Sumit Bhattacharyya, InSug O-Sullivan, Joanne K Tobacman
Frontiers in Oncology
|
June 17, 2026
Effects of Arylsulfatase B and Pembrolizumab in combination on progression of metastatic melanoma in the B16F10 syngeneic mouse model
Sumit Bhattacharyya, Insug O-Sullivan, Joanne K Tobacman
Current Genomics
|
December 13, 2006
Antigenic Differences Between Normal and Malignant Cells as a Basis for Treatment of Intracerebral Neoplasms Using a DNA-Based Vaccine
Terry Lichtor, Roberta P Glick, Insug O-Sullivan, et al.
Immunotherapy
|
March 31, 2010
Enhancing cellular cancer vaccines
Edward P Cohen, Amla Chopra, InSug O-Sullivan, et al.
Anticancer Research
|
April 20, 2006
Therapeutic properties of DNA-based fibroblast and dendritic cell vaccines in mice with squamous carcinoma
Insug O-Sullivan, Tae Sung Kim, Amla Chopra, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
October 9, 2023
Exogenous recombinant N-acetylgalactosamine-4-sulfatase (Arylsulfatase B; ARSB) inhibits progression of B16F10 cutaneous melanomas and modulates cell signaling
Sumit Bhattacharyya, Insug O-Sullivan, Jieqi Tu, et al.
International Journal of Cancer
|
December 29, 2005
Combined therapy of an established, highly aggressive breast cancer in mice with paclitaxel and a unique DNA-based cell vaccine
Amla Chopra, Tae Sung Kim, Insug O-Sullivan, et al.
International Journal of Cancer
|
February 16, 2006
Treatment of squamous carcinoma in mice with a vaccine enriched for cells that induce immunity to squamous carcinoma--a new vaccination strategy
Amla Chopra, Tae Sung Kim, InSug O-Sullivan, et al.
Cancer Gene Therapy
|
April 2, 2005
Intratumoral injection of IL-secreting syngeneic/allogeneic fibroblasts transfected with DNA from breast cancer cells prolongs the survival of mice with intracerebral breast cancer
Terry Lichtor, Roberta P Glick, Henry Lin, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
Drug News & Perspectives
|
April 19, 2007
Enrichment of a squamous carcinoma vaccine
InSug O-Sullivan, Amla Chopra, Edward P Cohen
International Journal of Molecular Sciences
|
June 19, 2024
N-Acetylgalactosamine-4-sulfatase (Arylsulfatase B) Regulates PD-L1 Expression in Melanoma by an HDAC3-Mediated Epigenetic Mechanism
Sumit Bhattacharyya, InSug O-Sullivan, Joanne K Tobacman
Frontiers in Oncology
|
June 17, 2026
Effects of Arylsulfatase B and Pembrolizumab in combination on progression of metastatic melanoma in the B16F10 syngeneic mouse model
Sumit Bhattacharyya, Insug O-Sullivan, Joanne K Tobacman
Current Genomics
|
December 13, 2006
Antigenic Differences Between Normal and Malignant Cells as a Basis for Treatment of Intracerebral Neoplasms Using a DNA-Based Vaccine
Terry Lichtor, Roberta P Glick, Insug O-Sullivan, et al.
Immunotherapy
|
March 31, 2010
Enhancing cellular cancer vaccines
Edward P Cohen, Amla Chopra, InSug O-Sullivan, et al.
Anticancer Research
|
April 20, 2006
Therapeutic properties of DNA-based fibroblast and dendritic cell vaccines in mice with squamous carcinoma
Insug O-Sullivan, Tae Sung Kim, Amla Chopra, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
October 9, 2023
Exogenous recombinant N-acetylgalactosamine-4-sulfatase (Arylsulfatase B; ARSB) inhibits progression of B16F10 cutaneous melanomas and modulates cell signaling
Sumit Bhattacharyya, Insug O-Sullivan, Jieqi Tu, et al.
International Journal of Cancer
|
December 29, 2005
Combined therapy of an established, highly aggressive breast cancer in mice with paclitaxel and a unique DNA-based cell vaccine
Amla Chopra, Tae Sung Kim, Insug O-Sullivan, et al.
International Journal of Cancer
|
February 16, 2006
Treatment of squamous carcinoma in mice with a vaccine enriched for cells that induce immunity to squamous carcinoma--a new vaccination strategy
Amla Chopra, Tae Sung Kim, InSug O-Sullivan, et al.
Cancer Gene Therapy
|
April 2, 2005
Intratumoral injection of IL-secreting syngeneic/allogeneic fibroblasts transfected with DNA from breast cancer cells prolongs the survival of mice with intracerebral breast cancer
Terry Lichtor, Roberta P Glick, Henry Lin, et al.
Page
of 4